Company / Revenue per Share
NovaBay Pharmaceuticals, Inc. Revenue per Share History
FY2015-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$1.19
FY2017
5-year range
-
FY2015-FY2017
Trend
-65.0%
vs FY2016
Sector context
#100 of 152
Health Care
What the data says
At $1.19, NovaBay Pharmaceuticals, Inc.'s revenue per share ranks #100 of 152 in the Health Care sector. Declined from $2.12 to $1.19 over the past 2 years.
Based on SEC 10-K filings.
1.19 in FY2017.
Declined from $2.12 to $1.19 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#100 of 152 in Health CareTop 66% of 152This company $1.19 Sector average $10.34
▼
-88.4% below sector average
Key checks
Key Insights
- In FY2017, revenue per share decreased 65.0% year-over-year.
- Ranks #100 out of 152 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $1.19 | -65.0% |
| FY2016 | $3.41 | +60.9% |
| FY2015 | $2.12 | +25474.7% |
As of FY2017 · SEC 10-K · Updated Feb 28, 2026